| 中文同義詞 | PSD95抑制劑(TAT-NR2B9C);H-TYR-GLY-ARG-LYS-LYS-ARG-ARG-GLN-ARG-ARG-ARG-LYS-LEU-SER-SER-ILE-GLU-SER-ASP-VAL-OH;TAT-NR2B9C/NA-1;抑制劑多肽TAT-NR2B9C;(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S,53S,59S)-59-氨基-38-(3-氨基-3-氧代丙基)-26,47,50-三(4-氨基丁基)-14-((S)-仲丁基)-11-(2-羧乙基)-5-(羧甲基)-29,32,35,41,44,53-六(3-胍丙基)-8,17,20-三(羥甲基)-60-(4-羥基苯基)-23-異丁基-2-異丙基-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-十九碳烷-3,6,9,12,15,18,21,24,27,;化合物 TAT-NR2B9C;YGRKKRRQRRRKLSSIESDV;(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S,53S,59S)-59-氨基-38-(3-氨基-3-氧代丙基)-26,47,50-三(4-氨基丁基)-14-((S)-仲丁基)-11-(2-羧乙基)-5-(羧甲基)-29,32,35,41,44,53-六(3-胍丙基)-8,17,20-三(羥甲基)-60-(4-羥基苯基)-23-異丁基-2-異丙基-4,7,10,13,16,19,22,25,28,31,34,37, |
|---|
| 英文同義詞 | Tat-NR2B9c;Tat-NR2B9c, >98%;L-Valine, L-tyrosylglycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-arginyl-L-lysyl-L-leucyl-L-seryl-L-seryl-L-isoleucyl-L-α-glutamyl-L-seryl-L-α-aspartyl-;Tat-NR2B9c/NA-1;500992-11-0/1834571-04-8;(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S,53S,59S)-59-Amino-38-(3-amino-3-oxopropyl)-26,47,50-tris(4-aminobutyl)-14-((S)-sec-butyl)-11-(2-carboxyethyl)-5-(carboxymethyl)-29,32,35,41,44,53-hexakis(3-guanidinopropyl)-8,17,20-tris(hydroxymethyl)-60-(4-hydroxyphenyl)-23-isobutyl-2-isopropyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58-nonadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-nonadecaazahexacontanoic acid;Tat-NR2Bct|||NA-1;Tat-NR2B9c trifluoroacetate |
|---|
